Main container

Utilizzo di PRP ricco di leucociti o PRP privo di leucociti nel trattamento dell’osteoartrite d’anca

Title
Utilizzo di PRP ricco di leucociti o PRP privo di leucociti nel trattamento dell’osteoartrite d’anca
Code
PRP22-Hip
Type
Sperimentale
Start Year
2022
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
20/06/2022 16:51